Orchard Therapeutics Announces Agreement Enabling Reimbursed Access to Libmeldy for All Eligible MLD Patients in Sweden
BOSTON and LONDON, Feb. 27, 2023 -- Orchard Therapeutics , a global gene therapy leader, today announced it has reached an agreement with the New Therapies Council which will result in reimbursed... | February 27, 2023
Source: marketscreener.com